COMPARISON BETWEEN SERUM CREATININE AND SERUM CYSTATIN C LEVEL IN DIAGNOSING EARLY DIABETIC NEPHROPATHY IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS

Authors

  • Janmeshwar Prasad Senior Resident, Department of Medicine, AIIMS, Patna
  • Manish Kumar Singh Senior Resident, Department of Medicine, AIIMS, Patna
  • Md. Rashid Anwer Senior Resident, Department of Medicine, AIIMS, Patna
  • Shyama . Assistant Prof, Department of Medicine, AIIMS, Patna

DOI:

https://doi.org/10.32553/ijmbs.v5i4.1867

Keywords:

Cystatin C, Diabetic Nephropathies, Albuminuria

Abstract

Background: This study was done to evaluate clinical usefulness of cystatin C levels of serum and urine in predicting renal impairment in normoalbuminuric patients with type 2 diabetes and to evaluate the association between albuminuria and serum/urine cystatin C. Cockroft-Gault equation was previously used for GFR calculation. The most recently advocated formula for calculating the GFR are The modification of diet in renal disease study group ,CKD-EPI equation(2009),CKD-EPI cystatin C(2012), CKD-EPI creatinine –cystatin C(2012). The cystatin C levels of serum and urine could be useful markers for renal dysfunction in type 2 diabetic patients with normoalbuminuria.

Conclusion; This finding has major implications for clinical research and early intervention to prevent development of chronic kidney disease in patients with type 2 Diabetes mellitus.

Keywords: Cystatin C, Diabetic Nephropathies, Albuminuria

Downloads

Published

2021-04-14

How to Cite

Prasad, J. ., Singh, M. K. ., Anwer, M. R. ., & ., S. (2021). COMPARISON BETWEEN SERUM CREATININE AND SERUM CYSTATIN C LEVEL IN DIAGNOSING EARLY DIABETIC NEPHROPATHY IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS. International Journal of Medical and Biomedical Studies, 5(4). https://doi.org/10.32553/ijmbs.v5i4.1867

Issue

Vol. 5 No. 4 (2021)

Section

Articles

License

Copyright (c) 2021 International Journal of Medical and Biomedical Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.